Evidence map›Paper›PMID 42840764›Full record

ArticleInternational medical case reports journal2026

Markedly Elevated CA 19-9 in Type I Mirizzi Syndrome in the Absence of Malignancy: A Case Report.

Abdullahi Khalif Ali, Abdikani Mohamednor Mohamed, Abdirahman Ahmed Mohamud, Abdinasir Mohamed Elmi, Nimo Mohamednor Mohamed, Abdirahman Abdullahi Hassan

Abstract readCase Reports
In one paragraph

Article in International medical case reports journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Abdullahi Khalif AliDepartment of General Surgery, Mogadishu Somali Turkish Training and Research Hospital, Mogadishu, Somalia.ORCID 0009-0003-9104-3865
Abdikani Mohamednor MohamedFaculty of Medicine and Surgery, Somali National University, Mogadishu, Somalia.ORCID 0009-0000-6075-2798
Abdirahman Ahmed MohamudDepartment of General Surgery, Mogadishu Somali Turkish Training and Research Hospital, Mogadishu, Somalia.ORCID 0000-0001-7889-7231
Abdinasir Mohamed ElmiRadiology Department, Mogadishu Somali Turkish Training and Research Hospital, Mogadishu, Somalia.
Nimo Mohamednor MohamedFaculty of Medicine and Surgery, Somali National University, Mogadishu, Somalia.
Abdirahman Abdullahi HassanFaculty of Medicine and Surgery, Al Hayat Medical University, Mogadishu, Somalia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Mirizzi syndrome (MS) is a rare complication of long-standing cholelithiasis in which an impacted gallstone causes extrinsic compression of the common hepatic duct. Markedly elevated carbohydrate antigen 19-9 (CA 19-9) is strongly associated with pancreaticobiliary malignancies, but severe benign biliary obstruction can also cause substantial elevations, presenting a diagnostic challenge. We present a 50-year-old man with acute obstructive jaundice, fever, right upper quadrant pain, and a serum CA 19-9 level of 1000 U/mL. Triphasic contrast-enhanced computed tomography confirmed Type I Mirizzi syndrome caused by an 11.9-mm gallstone impacted in Hartmann's pouch, with no evidence of malignancy. Due to dense adhesions obliterating Calot's triangle, the patient underwent subtotal (fenestrating) cholecystectomy. Postoperatively, cholestatic liver tests markedly improved, and CA 19-9 decreased to 153 U/mL, supporting a benign obstructive and inflammatory etiology. This case highlights the importance of considering Mirizzi syndrome in patients with obstructive jaundice and markedly elevated CA 19-9 to avoid misdiagnosis and unnecessary aggressive surgical intervention.

Indexed as

CA-19-9 AntigenMirizzi SyndromeCholecystectomyHumansJaundice, ObstructiveMaleMiddle AgedTomography, X-Ray ComputedCA-19-9 Antigenbiliary obstructionCA 19-9carbohydrate antigen 19-9mirizzi syndromeobstructive jaundicesubtotal cholecystectomy

Identifiers

PMID42840764
PMCPMC13641110

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.